美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=NDA021777"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
71335-2696-1 71335-2696 HUMAN PRESCRIPTION DRUG Cyclobenzaprine Hydrochloride Cyclobenzaprine Hydrochloride CAPSULE, EXTENDED RELEASE ORAL 20250924 N/A NDA AUTHORIZED GENERIC NDA021777 Bryant Ranch Prepack CYCLOBENZAPRINE HYDROCHLORIDE 30 mg/1 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71335-2696-1)
71335-2696-2 71335-2696 HUMAN PRESCRIPTION DRUG Cyclobenzaprine Hydrochloride Cyclobenzaprine Hydrochloride CAPSULE, EXTENDED RELEASE ORAL 20250924 N/A NDA AUTHORIZED GENERIC NDA021777 Bryant Ranch Prepack CYCLOBENZAPRINE HYDROCHLORIDE 30 mg/1 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71335-2696-2)
72189-389-60 72189-389 HUMAN PRESCRIPTION DRUG Cyclobenzaprine HCL ER Cyclobenzaprine HCL ER CAPSULE, EXTENDED RELEASE ORAL 20221109 N/A NDA AUTHORIZED GENERIC NDA021777 Direct_Rx CYCLOBENZAPRINE HYDROCHLORIDE 15 mg/1 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (72189-389-60)
0115-1437-13 0115-1437 HUMAN PRESCRIPTION DRUG Cyclobenzaprine Hydrochloride Cyclobenzaprine Hydrochloride CAPSULE, EXTENDED RELEASE ORAL 20190301 N/A NDA AUTHORIZED GENERIC NDA021777 Amneal Pharmaceuticals of New York LLC CYCLOBENZAPRINE HYDROCHLORIDE 30 mg/1 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0115-1437-13)
0093-1921-06 0093-1921 HUMAN PRESCRIPTION DRUG Cyclobenzaprine Hydrochloride Cyclobenzaprine Hydrochloride CAPSULE, EXTENDED RELEASE ORAL 20190304 N/A NDA AUTHORIZED GENERIC NDA021777 Teva Pharmaceuticals USA, Inc. CYCLOBENZAPRINE HYDROCHLORIDE 30 mg/1 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0093-1921-06)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2025 Drugfuture->U.S. FDA National Drug Code DataBase